C81.9

Clinical Information

• A cancer of the immune system that is marked by the presence of a type of cell called the reed-sternberg cell. The two major types of hodgkin lymphoma are classical hodgkin lymphoma and nodular lymphocyte-predominant hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats.

• A lymphoma, previously known as hodgkin’s disease, characterized by the presence of reed-sternberg cells. There are two distinct subtypes: nodular lymphocyte predominant hodgkin lymphoma and classical hodgkin lymphoma. Hodgkin lymphoma has a bimodal age distribution, and involves primarily lymph nodes. Current therapy for hodgkin lymphoma has resulted in an excellent outcome and cure for the majority of patients.

• A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate hodgkin’s and reed-sternberg cells are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

• A malignant disease of the lymphatic system that is characterized by painless enlargement of lymph nodes, the spleen, or other lymphatic tissue. It is sometimes accompanied by symptoms such as fever, weight loss, fatigue, and night sweats.

• An obsolete term referring to hodgkin lymphoma.

• Hodgkin disease is a type of lymphoma. lymphoma is cancer of lymph tissue found in the lymph nodes, spleen, liver, and bone marrow. The first sign of hodgkin disease is often an enlarged lymph node. The disease can spread to nearby lymph nodes. Later it may spread to the lungs, liver or bone marrow. The cause is unknown. Hodgkin disease is rare. Symptoms include

• Malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue, and the presence of large, usually multinucleate, cells reed-sternberg cells) of unknown origin.

Details

• C81.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C81.9 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C81.9 – other international versions of ICD-10 C81.9 may differ.